Mammography Computer Aided Detection (Mammo CAD) Market in Western Europe, Forecast to 2022
This insight presents an analysis of the mammography CAD (computer aided detection) market in Western Europe. It provides an in-depth analysis of the current trends, market size, revenue forecast, market penetration and market attractiveness, both in the two dimensional (2D) and three dimensional (3D) CAD markets.
X-ray Mammography is the gold standard for breast cancer detection. With rising incidence of breast cancer, organized population based screening programs are carried out in Western countries at 1-3 year screening intervals, depending on the policies of individual countries. Starting early 1990s, countries in the region have witnessed a significant decrease in mortality. Mammography was not considered patient friendly due to the discomforts caused, possible false positives, failure to detect tumors and the potential radiation exposure. However, with innovations in technology, most western countries have switched to digital screening. Yet, the use of CAD is low in Western European countries and the guidelines prescribe double reading by radiologists for mammography interpretation. CAD algorithms aid in the diagnosis and visualization of mammography data. They process 2D and 3D tomosynthesis mammography images and identify regions of interest in breasts.
With the advent of private hospitals and favorable health insurance reimbursements, there is more demand for patient safety and quality of technologies, reduced hospitalization and a reduction in the overall healthcare costs. Business models focusing on managed services, pay per use, sharing services, integrated workflow and automation are changing the procurement landscape of mammography CAD solutions. These factors determine the growth of the mammography CAD market.
Market trends (Unit shipment of mammography and mammography CAD, Statistics on breast cancer procedure volume, radiologists, radiologists performing mammography, potential for 2D and 3D mammography CAD adoption, growth indicators, market adoption and penetration by country, potential adoption by hospital settings, key drivers and restraints for each country, factors influencing return on investment, forecasts, pricing trends, future prospects, competitive structure, market metrics, market share, revenues, strategy).
Europe: Western Europe (Germany, The United Kingdom, Italy, France, Spain, Benelux (Belgium, Netherlands, Luxembourg), Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden))
Analysis by 2D and 3D Mammography CAD by countries is provided.
Market measurements are analyzed for the year 2017 and forecast up to 2022 – Revenue and Year-on-Year growth rate by countries and segments. Pricing range and growth trends by sub-segment for the base year are discussed.
Strategies, growth analysis, competitive landscape, and future focus are discussed for vendors (prominent among which are GE Healthcare, Siemens Healthineers, Hologic, IMS, Planmed, Fujifilm, ICAD and Screen Point).